# Massive Pericardial Effusion and Type 3 Cardiorenal Syndrome as the Inaugural Presentation of Late-Onset Systemic Lupus Erythematosus in a Septuagenarian

**Authors:** Sergio David Angulo, Cesar Cortes, Manuela Orozco, Juan Diego Trujillo Loaiza, Diego Ruiz, Juan Pablo Rodríguez, Laura Fernanda Giraldo Nieto

PMC · DOI: 10.7759/cureus.102066 · 2026-01-22

## TL;DR

A 70-year-old woman presented with heart and kidney issues as her first signs of late-onset lupus.

## Contribution

This case highlights unique clinical features of late-onset SLE, specifically cardiac and serous membrane involvement.

## Key findings

- Late-onset SLE can present with massive pericardial effusion and cardiorenal syndrome.
- Class IV lupus nephritis was confirmed in the patient using updated diagnostic criteria.
- Cardiac involvement is more common in late-onset SLE compared to classical SLE.

## Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by inflammation and immune-mediated damage with mucocutaneous, musculoskeletal, cardiopulmonary, and renal involvement. It typically affects younger women; however, late-onset presentations can occur and often display distinct clinical features. We report the case of a septuagenarian woman who presented with massive pericardial effusion and type 3 cardiorenal syndrome. Further evaluation revealed class IV lupus nephritis, confirming a diagnosis of late-onset SLE according to the 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) criteria. Cardiac and serous membrane involvement is more common in late-onset SLE than in classical SLE.

## Linked entities

- **Diseases:** Systemic lupus erythematosus (MONDO:0007915), lupus nephritis (MONDO:0005556), cardiorenal syndrome (MONDO:0044079)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, RNPC3 (RNA binding region (RNP1, RRM) containing 3) [NCBI Gene 55599] {aka CPHD7, IGHD5, RBM40, RNP, SNRNP65}, SSB (small RNA binding exonuclease protection factor La) [NCBI Gene 6741] {aka LARP3, La, La/SSB, SSB/La}, TRIM21 (tripartite motif containing 21) [NCBI Gene 6737] {aka RNF81, RO52, Ro/SSA, SSA, SSA1, TRIM21/Ro52}
- **Diseases:** hypoalbuminemia (MESH:D034141), acute kidney injury (MESH:D058186), lupus myocarditis (MESH:D009205), immune-mediated damage (MESH:C567355), neuropsychiatric manifestations (MESH:D012877), myocardial damage (MESH:D009202), azotemia (MESH:D053099), nephritis (MESH:D009393), alopecia (MESH:D000505), autoimmune disease (MESH:D001327), infiltrates (MESH:D017254), pleural and pericardial effusions (MESH:D010996), hypoxemia (MESH:D000860), Pericardial Effusion (MESH:D010490), SLE (MESH:D008180), proteinuria (MESH:D011507), nephrotic (MESH:D009404), mitochondrial dysfunction (MESH:D028361), volume overload (MESH:D019190), pulmonary involvement (MESH:C566343), inflammation (MESH:D007249), anasarca (MESH:D004487), atrophy (MESH:D001284), lung disease (MESH:D008171), class IV lupus nephritis (MESH:D008181), malignancy (MESH:D009369), dyspnea (MESH:D004417), malar rash (MESH:C000721270), cardiac (MESH:D006331), cardiomegaly (MESH:D006332), serositis (MESH:D012700), cardiac decompensation (MESH:D006333), nephropathy (MESH:D007674), Cardiac and serous membrane involvement (MESH:D015433), cardiac pre-tamponade (MESH:D002305), asthenia (MESH:D001247), ventricular hypokinesis (MESH:D014693), pleuritis (MESH:D010998), hypertension (MESH:D006973), glomerulonephritis (MESH:D005921), inspiratory collapse (MESH:D001261), pericarditis (MESH:D010493), CRS (MESH:D059347), diastolic collapse of the right atrium (MESH:D006337), cardiopulmonary, and renal involvement (MESH:C565423), systemic injury (MESH:D057772), membranoproliferative glomerulonephritis (MESH:D015432), effusion (MESH:D000080324), infections (MESH:D007239)
- **Chemicals:** methylprednisolone (MESH:D008775), cyclophosphamide (MESH:D003520), aldosterone (MESH:D000450), creatinine (MESH:D003404), hydroxychloroquine (MESH:D006886)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12924641/full.md

---
Source: https://tomesphere.com/paper/PMC12924641